Pharma under the microscope as FTC considers new ways to review acquisitions

Pharma under the microscope as FTC considers new ways to review acquisitions

Source: 
BioPharma Dive
News Tags: 
snippet: 

Drugmaker acquisitions of all sizes could receive closer scrutiny in the future if the Federal Trade Commission follows the advice of experts who spoke at a two-day agency meeting on market concentration and anticompetitive conduct.